Clinical Trial Update: Effects of GLYX-13 on Learning and Memory in Healthy Individuals and Those With Psychiatric Illness [Phase 2]

View source ↗

Summary

Phase 2 trial updating effects of GLYX-13 on learning and memory in healthy individuals and those with psychiatric illness; study terminated with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychiatric Disorders

Drugs mentioned

• GLYX-13 (Rapastinel)

Snippet

Sponsor: Northwestern University | Conditions: Psychiatric Illness, Healthy | Phase 2 | Status: TERMINATED | Results posted: 2023-04-20